Topic Statement:
Divi's Laboratories has shown resilience amidst the broad market correction, with stable price movements and potential for accumulation near the 180-day moving average.
Key points:
1. Company reported a profit growth of 64% QoQ for the third quarter.
2. Price broke down from the up-trending channel, transitioning into a sideways pattern.
3. Strong resistance is present at the 6000 level.
4. The stock repeatedly approaches the 180-day moving average, presenting a good buying opportunity.
Divi's Laboratories has shown resilience amidst the broad market correction, with stable price movements and potential for accumulation near the 180-day moving average.
Key points:
1. Company reported a profit growth of 64% QoQ for the third quarter.
2. Price broke down from the up-trending channel, transitioning into a sideways pattern.
3. Strong resistance is present at the 6000 level.
4. The stock repeatedly approaches the 180-day moving average, presenting a good buying opportunity.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。